Pediatrix (MD) Director Kurt Newman Receives 472-Share Award

What Happened
Kurt Douglas Newman, a director of Pediatrix Medical Group, received an equity award of 472 restricted shares on 2026-08-12. The grant price was reported at $26.50 per share, for a total grant value of $12,508. This was an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-12; Form 4 filed 2026-08-14 (appears timely).
• Instrument: Restricted common shares granted under the Issuer’s Second Amended and Restated 2008 Incentive Compensation Plan.
• Quantity and price: 472 shares at $26.50 per share; total value $12,508.
• Vesting: Shares will vest on May 7, 2027 (see footnote).
• Shares owned after transaction: Not specified in the provided filing.
• Transaction code: A = Award/Grant. No 10b5-1 plan, tax withholding, or other special handling noted in the filing.

Context
This is a standard director equity award (restricted shares) intended as compensation and retention; such grants are routine and do not themselves indicate a buy or sell signal. The award increases Newman’s equity stake once vested, but the filing does not report his post-transaction holdings.